Liang Jing

6PUBLICATIONS
73CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)Predictive and prognostic markersDisease surveillanceTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 14, 2026
Higher Incidence of Hepatocellular Carcinoma in Suppressed Hepatitis B Cirrhosis Compared With Cured Hepatitis C Cirrhosis.

|Jan 13, 2025
The Development and Appraisal of MELD 3.0 in Liver Diseases: Good Things Never Come Easy.

Gaoyue Guo, Wanting Yang, Jia Li

|Jul 10, 2022
Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study.

Xiaolong Qi, Jitao Wang, Qiran Zhang

|May 09, 2022
Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study.

Wencong Li, Jing Liang, Jihong An

|Aug 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b.

Fanpu Ji, Jie Li, Li Liu

|Jun 05, 2020
Liver cirrhosis in a patient with hepatic hereditary hemorrhagic telangiectasia and Budd-Chiari syndrome: a case report.

Bai-Guo Xu, Jing Liang, Ke-Feng Jia

Pageof 1

Frequent Collaborators

2 joint publications

Tao Han

2 joint publications

Fanpu Ji

2 joint publications

Mindie Nguyen

1 joint publications

Bai-Guo Xu